STK33 抗体
Recommended next Filters:
您想试用我们的人工智能搜索吗?
69 results :
Latest Publications for our STK33 抗体
: "Targeting of KRAS mutant tumors by HSP90 inhibitors involves degradation of STK33." in: The Journal of experimental medicine, Vol. 209, Issue 4, pp. 697-711, (2012) (PubMed).: "STK33 kinase activity is nonessential in KRAS-dependent cancer cells." in: Cancer research, Vol. 71, Issue 17, pp. 5818-26, (2011) (PubMed).
: "Synthetic lethal interaction between oncogenic KRAS dependency and STK33 suppression in human cancer cells." in: Cell, Vol. 137, Issue 5, pp. 821-34, (2009) (PubMed).
: "Phosphoinositide 3-kinase signalling pathways." in: Journal of cell science, Vol. 114, Issue Pt 8, pp. 1439-45, (2001) (PubMed).
: "Oncogenic kinase signalling." in: Nature, Vol. 411, Issue 6835, pp. 355-65, (2001) (PubMed).
: "The RET proto-oncogene in human cancers." in: Oncogene, Vol. 19, Issue 49, pp. 5590-7, (2000) (PubMed).
Aliases for STK33 抗体
serine/threonine kinase 33 (STK33) 抗体serine/threonine kinase 33 (Stk33) 抗体
4921505G21Rik 抗体
AW061264 抗体
您还需要查找其他产品吗?
- STK32C 抗体
- STK32B 抗体
- STK32A 抗体
- STK31 抗体
- STK3 抗体
- STK26/MST4 抗体
- STK19 抗体
- STK17A 抗体
- STK16 抗体
- STK11IP 抗体
- STK10-A 抗体
- STIP1 Homology and U-Box Containing Protein 1 抗体
- STIP1 抗体
- STING/TMEM173 抗体
- Stim2 抗体
- STIM1 抗体
- STIL 抗体
- Sterol Carrier Protein 2 抗体
- Steroid-5-alpha-Reductase, alpha Polypeptide 2 (3-Oxo-5 alpha-Steroid delta 4-Dehydrogenase alpha 2) 抗体
- Stereocilin 抗体